259 related articles for article (PubMed ID: 32243712)
21. Foveal geographic atrophy following intravitreal pegaptanib sodium (Macugen) for drusenoid pigment epithelium detachment.
Querques G; Bux AV; Delle Noci N
Eur J Ophthalmol; 2009; 19(5):890-3. PubMed ID: 19787618
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration.
Roquet W; Roudot-Thoraval F; Coscas G; Soubrane G
Br J Ophthalmol; 2004 May; 88(5):638-42. PubMed ID: 15090415
[TBL] [Abstract][Full Text] [Related]
23. Optical coherence tomography appearance of "drusenoid" pigment epithelial detachment.
Emfietzoglou I; Grigoropoulos V; Kipioti A; Alimisi S; Theodossiadis PG; Theodossiadis GP
Ophthalmic Surg Lasers Imaging; 2005; 36(2):147-50. PubMed ID: 15792317
[TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography angiography findings of the fellow eye of patients with unilateral neovascular age-related macular degeneration OCT-A Evaluation of Fellow Eyes of CNV.
Emre S; Ulusoy MO
Rom J Ophthalmol; 2019; 63(3):231-237. PubMed ID: 31687624
[No Abstract] [Full Text] [Related]
25. Multimodal imaging in early onset non-neovascular pigment epithelial detachments.
Goudot MM; Rothschild PR; Bauters G; Vagge A; Miere A; Souied EH; Behar-Cohen F; Bernabei F
Eur J Ophthalmol; 2024 Jan; 34(1):NP118-NP122. PubMed ID: 37424318
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of aflibercept in pigment epithelial detachments secondary to neovascular age related macular degeneration.
Diaconita V; Li B; Pal L; Bahnacy F; Gonder JR
Can J Ophthalmol; 2019 Oct; 54(5):626-634. PubMed ID: 31564356
[TBL] [Abstract][Full Text] [Related]
27. PHOTOBIOMODULATION THERAPY FOR LARGE SOFT DRUSEN AND DRUSENOID PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: A Single-Center Prospective Pilot Study.
Benlahbib M; Cohen SY; Torrell N; Colantuono D; Crincoli E; Amoroso F; Semoun O; Jung C; Souied EH
Retina; 2023 Aug; 43(8):1246-1254. PubMed ID: 37027819
[TBL] [Abstract][Full Text] [Related]
28. Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration.
Kim MS; Ryoo NK; Park KH
Sci Rep; 2020 Sep; 10(1):14370. PubMed ID: 32873842
[TBL] [Abstract][Full Text] [Related]
29. Combined Fundus Autofluorescence and Near Infrared Reflectance as Prognostic Biomarkers for Visual Acuity in Foveal-Sparing Geographic Atrophy.
Lindner M; Nadal J; Mauschitz MM; Lüning A; Czauderna J; Pfau M; Schmitz-Valckenberg S; Holz FG; Schmid M; Fleckenstein M
Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO61-BIO67. PubMed ID: 28475704
[TBL] [Abstract][Full Text] [Related]
30. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY
Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796
[TBL] [Abstract][Full Text] [Related]
31. Natural course of adult-onset vitelliform lesions in eyes with and without comorbid subretinal drusenoid deposits.
Wilde C; Awad M; Giannouladis K; Lakshmanan A; Yeung AM; Dua H; Amoaku WMK
Int Ophthalmol; 2020 Jun; 40(6):1501-1508. PubMed ID: 32130624
[TBL] [Abstract][Full Text] [Related]
32. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
[TBL] [Abstract][Full Text] [Related]
33. ANATOMIC AND FUNCTIONAL IMPROVEMENT OF A DRUSENOID PIGMENT EPITHELIAL DETACHMENT: A CASE REPORT.
Csaky KG; Christie AH
Retin Cases Brief Rep; 2022 May; 16(3):318-321. PubMed ID: 31958105
[TBL] [Abstract][Full Text] [Related]
34. OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS FOR REDUCTION OF DRUSENOID PIGMENT EPITHELIUM DETACHMENT.
Kim M; Lee YJ; Park W; Park YG; Park YH
Retina; 2021 Feb; 41(2):402-408. PubMed ID: 32379166
[TBL] [Abstract][Full Text] [Related]
35. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
36. Cuticular Drusen: Clinical Phenotypes and Natural History Defined Using Multimodal Imaging.
Balaratnasingam C; Cherepanoff S; Dolz-Marco R; Killingsworth M; Chen FK; Mendis R; Mrejen S; Too LK; Gal-Or O; Curcio CA; Freund KB; Yannuzzi LA
Ophthalmology; 2018 Jan; 125(1):100-118. PubMed ID: 28964580
[TBL] [Abstract][Full Text] [Related]
37. Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration.
Hirami Y; Mandai M; Takahashi M; Teramukai S; Tada H; Yoshimura N
Jpn J Ophthalmol; 2009 Jul; 53(4):396-407. PubMed ID: 19763758
[TBL] [Abstract][Full Text] [Related]
38. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.
Folgar FA; Yuan EL; Sevilla MB; Chiu SJ; Farsiu S; Chew EY; Toth CA;
Ophthalmology; 2016 Jan; 123(1):39-50.e1. PubMed ID: 26578448
[TBL] [Abstract][Full Text] [Related]
39. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B
Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633
[TBL] [Abstract][Full Text] [Related]
40. MORPHOLOGIC FEATURES OF THE RETINAL PIGMENT EPITHELIUM AND ASSOCIATED CHORIORETINAL CHARACTERISTICS IN EYES WITH EARLY AGE-RELATED MACULAR DEGENERATION AND SUBRETINAL DRUSENOID DEPOSITS.
Jang S; Park SY; Ahn SM; Hwang SY; Kim SW; Oh J; Yun C
Retina; 2020 Apr; 40(4):686-694. PubMed ID: 30950969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
